Results 241 to 250 of about 7,204,743 (394)

Excitatory neurons in stratum radiatum provide an alternative pathway for excitation flow that escapes perisomatic inhibition [PDF]

Julia Lebedeva, David Jappy, Azat Nasretdinov, Alina Vazetdinova, Viktoria Krut, Rostislav I. Sokolov, Yulia Dobryakova, Marina Eliava, Valery Grinevich, Andrei Rozov   +9 more
openalex   +1 more source

An alternative pathway for bone destruction in inflammatory arthritis? [PDF]

, 2012
Katrina Ray
openalex   +1 more source

Plecstatin inhibits hepatocellular carcinoma tumorigenesis and invasion through cytolinker plectin

Molecular Oncology, EarlyView.
The ruthenium‐based metallodrug plecstatin exerts its anticancer effect in hepatocellular carcinoma (HCC) primarily through selective targeting of plectin. By disrupting plectin‐mediated cytoskeletal organization, plecstatin inhibits anchorage‐dependent growth, cell polarization, and tumor cell dissemination.
Zuzana Outla, Jan Kosla, Magdalena Prechova, Lukas Frick, Patricia Bortel, Yasmin Borutzki, Andrea Bileck, Christopher Gerner, Samuel M. Meier‐Menches, Selma Osmanagic‐Myers, Martin Gregor   +10 more
wiley   +1 more source

Pediatric Immunodeficiency Caused by Complement Classical and Alternative Pathway Defects Due to a Homozygous CFI Variant: A Case Report. [PDF]

Cureus
Wei J, Liu C, Tian M, Cao G, Li J.
europepmc   +1 more source

The potential role of complement alternative pathway activation in hypertensive renal damage. [PDF]

Exp Biol Med (Maywood), 2022
Wang C, Wang Z, Zhang W.
europepmc   +1 more source

Recurrent cancer‐associated ERBB4 mutations are transforming and confer resistance to targeted therapies

Molecular Oncology, EarlyView.
We show that the majority of the 18 analyzed recurrent cancer‐associated ERBB4 mutations are transforming. The most potent mutations are activating, co‐operate with other ERBB receptors, and are sensitive to pan‐ERBB inhibitors. Activating ERBB4 mutations also promote therapy resistance in EGFR‐mutant lung cancer.
Veera K. Ojala, Sini Ahonen, Sara Peltola, Aura Tuohisto‐Kokko, Olaya Esparta, Peppi Suominen, Anne Jokilammi, Iman Farahani, Deepankar Chakroborty, Nikol Dibus, Steffen Boettcher, Tomi T. Airenne, Mark S. Johnson, Lisa D. Eli, Klaus Elenius, Kari J. Kurppa   +15 more
wiley   +1 more source

Differential effects of C5 inhibition, C3 inhibition, and alternative pathway inhibition on bacterial killing in vitro. [PDF]

Blood Adv
Ter Avest M, de Boer Z, Langemeijer SMC, van de Kar NCAJ, de Jonge MI, Ter Heine R, Langereis JD.   +6 more
europepmc   +1 more source

Correction: A potent complement factor C3-specific nanobody inhibiting multiple functions in the alternative pathway of human and murine complement. [PDF]

J Biol Chem, 2023
Jensen RK, Pihl R, Gadeberg TAF, Jensen JK, Andersen KR, Thiel S, Laursen NS, Andersen GR.   +7 more
europepmc   +1 more source

Faculty Opinions recommendation of The parasexual cycle in Candida albicans provides an alternative pathway to meiosis for the formation of recombinant strains.

, 2008
John M. Logsdon
openalex   +2 more sources

Kidney Disease Caused by Dysregulation of the Complement Alternative Pathway: An Etiologic Approach.

Journal of the American Society of Nephrology, 2015
A. D. De Vriese, S. Sethi, J. V. Van Praet, K. Nath, F. Fervenza   +4 more
semanticscholar   +1 more source